NCT06746532View on ClinicalTrials.gov

Intranasal Breast Milk Therapy in HIE

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

December 31, 2030

Conditions
Hypoxic-Ischaemic EncephalopathyNeonatal EncephalopathyPerinatal AsphyxiaNeonatal Hypoxic Ischemic Encephalopathy
Interventions
BIOLOGICAL

Intranasal breast milk

"Own-mother's fresh breast milk (within 4 hours of having been expressed), is administered intranasally to neonates with hypoxic-ischemic encephalopathy receiving therapeutic hypothermia, starting from the first day of life and continuing for 28 days.~Dose: 2 times daily, 0.4 ml in each nostril."

Trial Locations (1)

1083

RECRUITING

Department of Neonatology, Pediatric Center, Semmelweis University, Budapest, Hungary, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER